$RSII Folks, Read between the lines of how special this new

New Post Public Reply Private Reply Replies (0) Message Board
southswell
4,519
$RSII Folks, Read between the lines of how special this new company, Rising BioSciences Inc., that Partners With PAO Group Inc. Alternative Medicine Centers of America $NWAV Sister Company. Rising will also be able to supply many others in my opinion.

Yes, we seen the Store from PAO VERY Early Thursday, but so many blind panic sellers took the time to sell shares of both $RSII and $NWAV before DD! BOTH DAYS!! Deserve to lose money that way.

MARIJUANA MOMO STOCK‏ @MOMOSTOCKTRADES Mar 2
More
$NWAV MEDICAL #MARIJUANA STORE GOES LIVE. SEE BELOW
pao.group/store/ THIS FINDING WAS THURSDAY MORNING!!!

Now, Robert has stated in Pr's between both Companies, they are Separate BUT there are SYNERGIES BETWEEN THEM! ONE DEVELOPS AND SUPPLIES, ONE TREATS AND SERVICES THE PATIENT. He has Huge goals for both and they will get accomplished, With or Without Panic Shareholders!

Cannabis Medicines, are in effect Compound drugs, which by definition are physically composed of multiple ingredients --- Cannabis being just one of the ingredients.



FROM THE FEB 15 PR: Letter of Intent with business operators that are currently active in the cannabis industry.

"Our team has met with business operators that have real experience and expertise in multiple states and several business verticals within the cannabis industry," commented Management. "The business focus will center on working with physicians and pharmacists groups on the Research and Development of new, cutting edge treatments within the medical cannabis industry

FROM FEB 23 RBI will acquire control of Rising India toward immediate execution of a business model with a focus in alternative medical and cannabis pharmaceutical markets.


Robert Weber "There are a number of opportunities in development and marketing of cannabis pharmaceuticals that are synergistic with our endeavors at PAO Group and BEYOND. Rising Biosciences plans to capitalize on these opportunities toward an assertive growth plan for shareholders alongside a highly expansive business model."

FROM FEB 27 Rising BioSciences, Inc. will be a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Aside from cancer treatment and pain management, some of the uses for medical marijuana include treatment of conditions such as seizure disorders, multiple sclerosis, Parkinson's disease, rheumatoid arthritis, glaucoma and Crohn's disease.

Rising Biosciences is comprised of a team of chemists, physicians, pharmacists and medical marijuana industry veterans for the development of products in a clinical lab environment. Operations will focus on creating product that can be metabolized by the body more efficiently, and with delivery methods more acceptable than smoking, tinctures and oils available on the market today.

Procedures will include consistency in terms of quality and true dosage measures of CBD and/or THC delivery through each product the company develops and manufactures.

To date, the industry suffers from a lack of overall quality control of product, including accurate dosage. Rising Biosciences intends to be an industry standout by using policies and procedures set forth by the compounding pharmaceutical industry while monitoring safety and quality throughout.

WHERE I AM GOING IS, THESE PEOPLE COMING ABOARD BOTH COMPANIES HAVE ALL THE KNOWLEDGE, KNOW HOW, CONNECTIONS TO THE CANNABIS INDUSTRY!! THIS HAS BEEN IN THE WORKS FOR MONTHS AND MONTHS.

AS FOR THE MERGER, I HAVE BEEN TOLD SOME CAN TAKE ONLY A FEW, FEW, FEW WEEKS TO COMPLETE!
AS FOR RUMORS BY SOME ON ISHIT*UB, RSI COULD BE BUYING IN THE OPEN MARKET, BUT ARE THEY?? THEY ARE ALLOWED 5% OF THE OS BEFORE ANY FILINGS TO THE SEC.

I WILL BE WATCHING FOR A FILING THAT SHOULD BE OUT 4 DAYS BEFORE THE CLOSING OF THE MERGER DETAILING FINANCIALS, WHO IS WHO.

THE POTENTIAL IS ENORMOUS FOLKS! DON'T SCARE SO EASY. TA CONFIRMED SHARE STRUCTURE. THERE IS NO NO DILUTION. JUST SHORTS CAUSING PANIC.

KNOW WHAT YOU OWN!

PLEASE JOIN US AT INVESTORS HANGOUT, CHECK OUT SHEEPWOLF'S $1,000,000 JOURNEY BOARD. WE ARE ALL HERE TO HELP ONE ANOTHER, NOT BASH, NOT PROVIDE FALSE FACTS TO GET A STOCK HIGHER OR LOWER. JUST DD AND GOOD COMPANY!

Rising India Inc (RBII) Stock Research Links

RBII Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading